Elevance Health, Inc. (ELV) reports insider transaction.
- Kaye Mark, EVP & CFO, sold 4,161 shares on 10/02/2026.
- Kaye Mark acquired 2,627 shares on 10/02/2026.
- Shares beneficially owned: 27,876 after sale, 30,503 after acquisition.
Mark Kaye
Every EDGAR filing for Elevance Health, Inc. (ELV), newest first, with AI summaries and stories.
Next: earnings expected ~Oct 19 · 10-Q expected ~Oct 19 (deadline Nov 9)
No open-market insider buys in the last 30 days.
Also: 2 grants or exercises.
Mark Kaye
Ryan R Craig, insider filing for ELV
Ryan R Craig, reporting
Ramiro G Peru, insider filing for ELV
Ramiro G Peru, reporting
Gail Boudreaux, insider filing for ELV
Gail Boudreaux, reporting
R Kerry Clark, planned sale of ELV shares
R Kerry Clark, reporting
Ronald W Penczek, insider filing for ELV
Ronald W Penczek, reporting
Ronald W Penczek, planned sale of ELV shares
Ronald W Penczek, reporting
Robert L Dixon JR, insider filing for ELV
Robert L Dixon Jr, reporting
Robert L Dixon JR, planned sale of ELV shares
Robert L Dixon Jr, reporting
Ronald W Penczek, insider filing for ELV
Ronald W Penczek, reporting
Ronald W Penczek, planned sale of ELV shares
Ronald W Penczek, reporting
Deanna D Strable-Soethout, insider filing for ELV
Deanna D Strable-soethout, reporting
Ownership stake disclosure by VANGUARD CAPITAL MANAGEMENT LLC
VANGUARD CAPITAL MANAGEMENT LLC, filed by
TRILLIUM ASSET MANAGEMENT, LLC, filed by
Ownership stake disclosure by VANGUARD GROUP INC (amended)
VANGUARD GROUP INC, filed by
Amy W Schulman, insider filing for ELV
Amy W Schulman, reporting
Charles Morgan Kendrick JR, insider filing for ELV
Charles Morgan Kendrick Jr, reporting
Charles Morgan Kendrick JR, planned sale of ELV shares
Charles Morgan Kendrick Jr, reporting
Steven H Collis, insider filing for ELV
Steven H Collis, reporting
Ronald W Penczek, insider filing for ELV
Ronald W Penczek, reporting